Citius Oncology (CTOR) Total Current Liabilities (2022 - 2026)

Citius Oncology (CTOR) has 5 years of Total Current Liabilities data on file, last reported at $58.8 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 18.24% year-over-year to $58.8 million in Q1 2026; TTM through Mar 2026 was $58.8 million, a 18.24% increase from a year earlier, with the FY2025 full-year figure at $49.5 million, up 51.35% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $58.8 million, up from $44.7 million in the prior quarter.
• Over the last five years, Total Current Liabilities for CTOR reached as high as $58.8 million in Q1 2026 and fell as low as $31836.0 in Q4 2022.
• Historically, Total Current Liabilities has averaged $25.8 million across 5 years, with a median of $26.9 million in 2023.
• Across the five-year window, Total Current Liabilities surged 6325.94% in 2023 and rose 3.02% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $31836.0 in 2022, then jumped by 6325.94% to $2.0 million in 2023, then surged by 2021.44% to $43.4 million in 2024, then climbed by 3.02% to $44.7 million in 2025, then soared by 31.54% to $58.8 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $58.8 million in Q1 2026, $44.7 million in Q4 2025, and $49.5 million in Q3 2025.